Loading
Antengene Corporation Ltd. - B Stock: price and insider trades · Hong Kong
5 insiders bought shares over the last 90 days, the latest by Fonseca Rafael, filed 16 Sept 2026.
Insider Decl.
46
Thresholds
n/a
Buy Volume
€233,128
30 ops. · all time
Sell Volume
€26,756
4 ops. · all time
Who traded when
BuySaleMei Jay4 buys
Lung Donald Andrew2 buys1 sale
Fonseca Rafael1 buy1 sale
Qian Jing1 buy1 sale
Hou Bing1 buy
Tang Sheng1 buy
Since the insiders bought
- -27.5%Entry HK$5.39 · Close at T+90 HK$3.91
- -38.0%Entry HK$4.70 · Close at T+90 HK$2.92
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 16,613 of 26,348 companies
43.2
score / 100
Value15
Quality71
FCF yld-10%
Earn yld-14%
EV/EBITDA·
ROE6.4%
Gross mgn84%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$3.02
Analyst consensus
1 analysts3.00/5
HK$4.87Target HK$4.87(+62%)HK$4.87
Income statement
RevenueHK$105.3M
Gross profitHK$88M84% margin
EBITDA-HK$212.8M-202% margin
Net income-HK$239.1M9.5% margin
Valuation
PER (trailing)33.5x
P/Book1.8x
Beta0.33
Balance sheet & cash
Market capHK$1.8B
Total debtHK$257.5M
Free Cash Flow-HK$178.9M
Debt / Equity28%
Profitability & ownership
ROE6.4%
ROA7.2%
% insiders37.1%
% institutions7.9%
Last declaration on 16 September 2026
Declarations46 total
200,000 sharesShareXHKGHKEX:DA20260915E00585
Canonical exit: 9 Dec 2026 (T+90)
200,000 sharesShareXHKGHKEX:DA20260915E00603
Canonical exit: 9 Dec 2026 (T+90)
200,000 sharesShareXHKGHKEX:DA20260915E00592
Canonical exit: 9 Dec 2026 (T+90)
1,450 shares@ HK$3.9913100.0% of flowShareXHKGHKEX:DA20260915E00591
2,000,000 sharesShareXHKGHKEX:DA20260915E00098
Canonical exit: 9 Dec 2026 (T+90)
70,000 sharesShareXHKGHKEX:DA20260915E00099
Canonical exit: 9 Dec 2026 (T+90)
2,372,337 sharesShareXHKGHKEX:DA20260810E00007
600,000 sharesShareXHKGHKEX:DA20260408E00251
Canonical exit: 1 Jul 2026 (T+90)
235,000 shares@ HK$4.1360.037% mcap48.2% of flowShareXHKGHKEX:DA20260324E00376
Canonical exit: 22 Jun 2026 (T+90)
100,000 shares@ HK$0.52310.0020% mcap51.0% of flowShareXHKGHKEX:DA20260324E00377
Canonical exit: 22 Jun 2026 (T+90)
267,500 shares@ HK$3.8930.040% mcap51.8% of flowShareXHKGHKEX:DA20260324E00233
Canonical exit: 21 Jun 2026 (T+90)
100,000 shares@ HK$0.50070.0019% mcap49.0% of flowShareXHKGHKEX:DA20260324E00208
Canonical exit: 21 Jun 2026 (T+90)
640,000 sharesShareXHKGHKEX:DA20260324E00230
50,000 shares@ HK$4.7006100.0% of flowShareXHKGHKEX:DA20251210E00021
175,927,994 sharesShareXHKGHKEX:DA20250526E00296
480,000 sharesShareXHKGHKEX:DA20250417E00386
1,000,000 sharesShareXHKGHKEX:DA20241004E00368
Canonical exit: 31 Dec 2024 (T+90)
670,000 sharesShareXHKGHKEX:DA20241004E00037
Canonical exit: 31 Dec 2024 (T+90)
200,000 sharesShareXHKGHKEX:DA20241004E00069
Canonical exit: 31 Dec 2024 (T+90)
200,000 sharesShareXHKGHKEX:DA20241004E00070
Canonical exit: 31 Dec 2024 (T+90)
200,000 sharesShareXHKGHKEX:DA20241004E00071
Canonical exit: 31 Dec 2024 (T+90)
0ShareXHKGHKEX:DA20240731E00268
3,000,000 sharesShareXHKGHKEX:DA20221116E00187
Canonical exit: 9 Feb 2023 (T+90)
500,000 sharesShareXHKGHKEX:DA20221115E00323
Canonical exit: 9 Feb 2023 (T+90)
500,000 sharesShareXHKGHKEX:DA20221115E00330
Canonical exit: 9 Feb 2023 (T+90)
25 of 46 declarations
About Antengene Corporation Ltd. - B
Antengene Corporation Ltd. - B, a healthcare company listed in Hong Kong (market capitalisation HKD 1,845.2 million, 37.1% held by insiders), has 46 filings, 30 of them purchases, with an amount on only 4 (EUR 233,128 in total, median EUR 56,306). The two largest are Lung Donald Andrew's, Director: EUR 114,987 on March 23, 2026 and EUR 106,861 on March 24, 2026. Mei Jay, Director, bought EUR 5,751 on March 24, 2026.
The 4 sales, 2 of them with an amount, are small: Fonseca Rafael, Director, EUR 26,034 on November 17, 2025, and Qian Jing, Director, EUR 722 on January 11, 2025. That gives 88% purchases among open-market trades. On November 11, 2022, 7 insiders filed purchases on the same day; 5 purchase filings are tied to it.
Read moreShow less
Mei Jay and Lung Donald Andrew are the most frequent, with 8 filings each. By year: 11 filings in 2021, 8 in 2022, 13 in 2026. Twelve are of another kind. Over the last twelve months, 14 filings, of which 10 purchases and 3 sales. Filings are published 4 days after the trade at the median.
